TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06129227

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Dual-task training
Description: This group will receive 30 min of dual-task exercise training and 30 min of stretching exercises in each session. The dual-task component involves walking activities performed in conjunction with cognitive activities. For the stretching exercise component, no cognitive load will be added.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Single-task training
Description: This group will undergo 30 min of single-task mobility training and another 30 min of single-task cognitive activities. The cognitive and mobility exercises will be the same as those in the dual-task group, but they will be performed separately. No extra cognitive load will be imposed during the mobility exercises. No additional motor demand will be imposed during the cognitive exercises, as the participants will be sitting.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Control group
Description: This group will undergo 30 min of stretching exercises (same as the dual-task group) and another 30 min of upper limb strengthening exercises performed primarily in the sitting or lying position. No cognitive load will be added.
Study: NCT04885296

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: TRP-200
Description: JJVC Investigational Contact Lens

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: TRP-200
Description: JJVC Investigational Contact Lens

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: JJVC Marketed Contact Lens
Description: ACUVUE Oasys 1-Day

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: JJVC Marketed Contact Lens
Description: ACUVUE Oasys 1-Day
Study: NCT04751669

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Vitamin and trace elements
Description: Dietary supplement oral route, once a day, during 14 days

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Dietary supplement (placebo) oral route, once a day, during 14 days
Study: NCT05397028

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Meal replacement system
Description: Participants will replace meals with a meal replacement system to assess the efficacy of weight loss leading to remission of diabetes (optimal A1C levels).

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Intensive lifestyle Intervention
Description: Participants will sign up with a virtual health program which they will interact with.
Study: NCT06277973

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Eye Movement Desensitization and Reprocessing (EMDR)
Description: The intervention is based on EMDR therapy for PTSD treatment. Participants will answer demographic questions, choose a primary distress source and watch a therapist-guided video (male or female, based on participant choice) that will instruct them through the 'Butterfly Hug' method (tapping alternately on both sides of the body) while hearing positive statements from the therapists on the chosen distress source. Before and after each video participants will rate their distress level on a scale between 0 and 10 and they can view up to 8 videos per session. The system will monitor distress levels, and if it detects a sustained deterioration, it will end the intervention. At the end of the intervention, participants will be given information about possible reactions to it and how to deal with them, they will be encouraged to use the technique whenever necessary, and they will be informed of relevant support lines that they can contact if needed.
Study: NCT05195060

Intervention type: DRUG
Intervention: casirivimab with imdevimab
Description: Monoclonal antibody
Study: NCT06277973

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Eye Movement Desensitization and Reprocessing (EMDR)
Description: The intervention is based on EMDR therapy for PTSD treatment. Participants will answer demographic questions, choose a primary distress source and watch a therapist-guided video (male or female, based on participant choice) that will instruct them through the 'Butterfly Hug' method (tapping alternately on both sides of the body) while hearing positive statements from the therapists on the chosen distress source. Before and after each video participants will rate their distress level on a scale between 0 and 10 and they can view up to 8 videos per session. The system will monitor distress levels, and if it detects a sustained deterioration, it will end the intervention. At the end of the intervention, participants will be given information about possible reactions to it and how to deal with them, they will be encouraged to use the technique whenever necessary, and they will be informed of relevant support lines that they can contact if needed.
Study: NCT04995094

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Imprime PGG
Description: Imprime PGG is a soluble, β-1,3/1,6 glucan isolated from the cell wall of a proprietary Saccharomyces cerevisiae yeast strain. Imprime PGG acts as a Pathogen-Associated Molecular Pattern (PAMP). Imprime will be administered at a dose of 4 mg/kg IV over a 2-hour infusion time on Days 1, 8 and 15 of each 3-week treatment cycle.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Pembrolizumab is a humanized monoclonal antibody against the programmed death receptor-1 (PD-1) protein. Pembrolizumab will be administered at 200 mg IV Q3W for 9 weeks.

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Pembrolizumab
Description: Pembrolizumab is a humanized monoclonal antibody against the programmed death receptor-1 (PD-1) protein. Pembrolizumab will be administered at 200 mg IV Q3W for 9 weeks.
Study: NCT05195060

Intervention type: DRUG
Intervention: sotrovimab
Description: Monoclonal antibody

Intervention type: DRUG
Intervention: molnupiravir
Description: antiviral agent
Study: NCT05631002

Intervention type: DIAGNOSTIC_TEST
Intervention: Chemical shift encoding-based water-fat MRI
Description: Chemical shift encoding-based water-fat magnetic resonance imaging (MRI): a non-invasive method

Intervention type: DIAGNOSTIC_TEST
Intervention: Chemical shift encoding-based water-fat MRI
Description: Chemical shift encoding-based water-fat magnetic resonance imaging (MRI): a non-invasive method

Intervention type: DIAGNOSTIC_TEST
Intervention: Chemical shift encoding-based water-fat MRI
Description: Chemical shift encoding-based water-fat magnetic resonance imaging (MRI): a non-invasive method
Study: NCT06225284

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Goserelin Acetate 3.6mg、Goserelin Acetate 10.8mg、Leuprolide Acetate 3.75mg、Leuprorelin Acetate 22.5mg、Triptorelin pamoate 11.25mg、Triptorelin pamoate 22.5mg
Description: After randomization, patients in the experimental arm (Arm A) will receive GnRH agonist injection within 3 days of randomization and during neoadjuvant chemotherapy treatment. The choice of GnRH agonist, including goserelin, leuprorelin and triptorelin giving in monthly, three-monthly or sixth-monthly, will be made by per investigator's discretion.
Study: NCT04939506

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: COVID-19 Vaccine Education at the Point of COVID-19 Testing
Description: A rapid vaccination education model to be delivered at the point of COVID-19 testing by pharmacy students, pharmacy technicians, nurse's aides and other health care personnel. The intervention will include: 1) 15 minute vaccine counseling, 2) print material 3) referral to a dedicated vaccine website with feedback forums and 4) opportunity to sign-up for one-on-one vaccine counseling with a clinical pharmacist
Study: NCT05957705

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Maxilar Sinus augmentation
Description: The patients will be submitted to bilateral sinus augmentation using two different techniques to provide enough bone tissue for dental implants placement.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Dental implant placement using guided surgery
Description: After 4 months of sinus augmentation, patients will be prepared to receive dental implants for oral rehabilitation. Performed by guided surgery the implants will be placed at the best location for the rehabilitation and at the place were the sinus lighting were performed.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Dental implant placement using guided surgery
Description: After 4 months of sinus augmentation, patients will be prepared to receive dental implants for oral rehabilitation. Performed by guided surgery the implants will be placed at the best location for the rehabilitation and at the place were the sinus lighting were performed.
Study: NCT06312696

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: SMT
Description: SMT will be provided by a licensed chiropractor with at least 5 years' experience.~Treatment will last 15 to 20 minutes each and include a brief history and examination of the cervical spine. SMT will consist of low velocity, variable amplitude spinal mobilization to the cervical spine - Maitland grades 3 or 4. Spinal segments will be determined by the chiropractor using manual palpation and the patients' response to care. Drop-table or instrument-assisted SMT will not be allowed.

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Light Massage
Description: Light Massage will be provided as a pseudo-sham intervention to control for time, attention, and touch by a licensed chiropractor with at least 5 years' experience to control for touch and is intended to be delivered gentler and shorter than recommended for therapeutic massage.
Study: NCT05750199

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Immunotherapy Special Training Course (ISTC)
Description: 16 weeks and includes 8 hours of digital media training and 2 days of workshop training.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Advanced Oncology Nurse Training Course (AONTC)
Description: 4 weeks and includes 8 days of Advanced Oncology Nurse Training Course
Study: NCT05363254

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Marlboro Gold Box
Description: A combustible cigarette

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Newport Box
Description: A combustible cigarette

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Non-combusted cigarette variant 42001401
Description: A menthol flavor variant of a non-combusted cigarette (42001401)

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Non-combusted cigarette variant 42001401
Description: A menthol flavor variant of a non-combusted cigarette (42001401)

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Non-combusted cigarette variant 42001399
Description: A menthol flavor variant of a non-combusted cigarette (42001399)

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Non-combusted cigarette variant 42001399
Description: A menthol flavor variant of a non-combusted cigarette (42001399)

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Non-combusted cigarette variant 40007386
Description: A menthol flavor variant of a non-combusted cigarette (40007386)

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Non-combusted cigarette variant 40007386
Description: A menthol flavor variant of a non-combusted cigarette (40007386)

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Non-combusted cigarette variant 42001402
Description: A non-menthol flavor variant of a non-combusted cigarette (42001402)

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Non-combusted cigarette variant 42001402
Description: A non-menthol flavor variant of a non-combusted cigarette (42001402)
Study: NCT04712240

Intervention type: DEVICE
Group type: OTHER
Intervention: Respiration rate monitor
Description: A portable continuously monitoring respiration rate monitor will be fitted to each participant. The respiration rate monitor is housed within a comfortable chest strap that be secured to the participant for the duration of the surgical procedure
Study: NCT04939688

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Conventional dose AND ultra low-dose CT scanning in the search for cranial lesions
Description: As well as undergoing the usual, conventional radiation dose CT scan, these patients will also undergo ultra low-dose CT scanning in the search for cranial lesions.
Study: NCT06286709

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Faecal Microbiota Transplant
Description: FMT is 50mL aliquots of filtered suspension of stool (0.6g/mL). FMT for administration via colonoscopy will be made up of 150g stool in 250mL (5 aliquots). FMT for administration via enema will be made up of 30g stool in 50mL (1 aliquot) made up to 100mL by the addition of 50mL normal saline

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: FMT Placebo
Description: FMT Placebo is 50mL aliquots containing 0.9% w/v saline and glycerol in a ratio of 9 parts saline: 1 part glycerol v/v. FMT Placebo for administration via colonoscopy will be made up of 250mL (5 aliquots). FMT Placebo for administration via enema will be made up of 50mL (1 aliquot) made up to 100mL by the addition of 50mL normal saline
Study: NCT05365685

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Low energy turnover
Description: Low Energy Turnover. The adolescents with ingest low energy intake at lunch and breakfast and will not perform physical exercise during the day. The will will receive an ad libitum meal at dinner time. Their food reward will be assessed before dinner. Their appetite feelings will be assessed at regular intervals.~Moderate Energy Turnover. The adolescents with ingest moderate energy intake at lunch and breakfast and will perform one 45 minutes physical exercise during the day. The will will receive an ad libitum meal at dinner time. Their food reward will be assessed before dinner. Their appetite feelings will be assessed at regular intervals.~High Energy Turnover. The adolescents with ingest high energy intake at lunch and breakfast and will perform two 45-minute physical exercises during the day. The will will receive an ad libitum meal at dinner time. Their food reward will be assessed before dinner. Their appetite feelings will be assessed at regular intervals.
Study: NCT06505733

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: postnatal attendant training
Description: Intervention Group: Training and counselling will be provided to the puerperant and companions before discharge in a quiet and stimulus-free environment using the Companion Training Guide. Research data will be collected three times: pre-test data, after the training and on the tenth day.
Study: NCT05683353

Intervention type: OTHER
Intervention: None intervention
Description: None intervention.

Intervention type: OTHER
Intervention: None intervention
Description: None intervention.
Study: NCT05303662

Intervention type: DIAGNOSTIC_TEST
Intervention: Multidrug-Resistant Organisms (MDRO) testing through rectal and oral/nasal swabs
Description: Pooled throat/nose sample and a rectal sample is taken prior to the ERCP

Intervention type: DIAGNOSTIC_TEST
Intervention: Multidrug-Resistant Organisms (MDRO) testing through rectal and oral/nasal swabs
Description: Pooled throat/nose sample and a rectal sample is taken prior to the ERCP

Intervention type: DIAGNOSTIC_TEST
Intervention: Multidrug-Resistant Organisms (MDRO) testing through rectal and oral/nasal swabs
Description: Pooled throat/nose sample and a rectal sample is taken prior to the ERCP

Intervention type: DIAGNOSTIC_TEST
Intervention: Multidrug-Resistant Organisms (MDRO) testing through rectal and oral/nasal swabs
Description: Pooled throat/nose sample and a rectal sample is taken prior to the ERCP

Intervention type: DIAGNOSTIC_TEST
Intervention: MDRO-testing duodenal aspirate
Description: Duodenal aspirate is collected from the duodenum, diluted and undiluted. Then cultured for presence of MDRO's

Intervention type: DIAGNOSTIC_TEST
Intervention: MDRO-testing duodenal aspirate
Description: Duodenal aspirate is collected from the duodenum, diluted and undiluted. Then cultured for presence of MDRO's

Intervention type: DIAGNOSTIC_TEST
Intervention: Microbiome through rectal swab
Description: An rectal swab is collected for microbiome purposes

Intervention type: DIAGNOSTIC_TEST
Intervention: Microbiome testing duodenal aspirate
Description: Duodenal aspirate is collected from the duodenum, diluted and undiluted for microbiome analysis
Study: NCT06485128

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Optical coherence tomography(-angiography) OCT(A)
Description: OCTA is a non-invasive diagnostic tool capable of generating cross-sectional coupes of the retina and choroid. Novel algorithms allow to render a 3-dimensional model of the ocular microcirculation based merely on the motion contrast of the circulating blood.
Study: NCT04966910

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Stay Connected
Description: Stay Connected is a menu-driven set of strategies to combat loneliness, anxiety and depression in older adults based on behavioral activation principles.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Treatment as usual
Description: Regular check-ins, resource/referral provision
Study: NCT04542603

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: [11C]PiB and 18F-labeled DPA-714 PET scan
Description: One PET with \[11C\]PiB and One PET with \[18F\]DPA-714 before chemotherapy treatment begins. One more PET with \[18F\]DPA-714 after completion of 3-6 cycles of chemotherapy.
Study: NCT04594278

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness Based Intervention
Description: A remotely delivered closed group mindfulness-based intervention using Microsoft Teams Meeting will be performed, consisting of 12-16 participants (Maximum 10 groups) and one professional with a background in mindfulness coaching . Three professionals will be coaching 2-3 groups each. The curriculum entails weekly sessions (1 hour) over a 4-week period.
Study: NCT06243523

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: The stress management psychoeducation program based on Neuman's Systems Model
Description: The stress management psychoeducation program will be implemented in six sessions with individual interviews lasting approximately 45-60 minutes, three times a week for the spouses of patients in intensive care. The first session includes the meeting and introduction of the psychoeducation program. The second session includes the adaptation process to the intensive care unit. The third, fourth and fifth sessions include methods of coping with stress. The sixth session includes evaluation and termination of the psychoeducational program. Quantitative data of the research will be collected with the pre-action and post-action Psychological Distress Scale and the Stress Coping Styles Scale. Qualitative data of the research will be collected through semi-structured individual in-depth interviews conducted after the action.
Study: NCT06485128

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Sphygmomanometer
Description: For the measurement of the blood pressure.

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Sphygmomanometer
Description: For the measurement of the blood pressure.

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Sphygmomanometer
Description: For the measurement of the blood pressure.

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Sphygmomanometer
Description: For the measurement of the blood pressure.

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Blood sample
Description: For both routine cardiovascular health biomarkers as well as genetic markers (DNA, mRNA, miRNA).
Study: NCT05778422

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Suprascapular nerve block with bipuvacaine
Description: Suprascapular nerve block with Bipuvacaine: a 50mm 22G needle (Stimuplex, BBraun) was introduced up to the suprascapular fossa, guided by ultrasound, and the location was confirmed by motor stimulation with contraction of the supraspinatus and infraspinatus muscles. Next, 5 ml of 0.25% bupivacaine with adrenaline was injected.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Pulsed radiofrequency
Description: After confirming the location, the needle mandrel was removed and the radiofrequency cannula was introduced through the needle, 2ml of 1% lidocaine without epinephrine was injected, followed by application of pulsed radiofrequency for 180sec at 42°C by radiofrequency (radiofrequency generator system BMS-50N, Bramsys).
Study: NCT06485128

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Blood sample
Description: For both routine cardiovascular health biomarkers as well as genetic markers (DNA, mRNA, miRNA).

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Blood sample
Description: For both routine cardiovascular health biomarkers as well as genetic markers (DNA, mRNA, miRNA).

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Blood sample
Description: For both routine cardiovascular health biomarkers as well as genetic markers (DNA, mRNA, miRNA).
Study: NCT06133725

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: erector spinae plane block
Description: The experimental group received ultrasound-guided erector spinae plane block, and bilateral erector spinae plane block was performed at T7 segment with 20ml 0.375% ropivacaine on each side.While the control group received ultrasound-guided transversus abdominis plane block combined with rectus sheath block, which will be performed under the costal margin with 10ml 0.375% ropivacaine for bilateral transversus abdominis plane block and 10ml 0.375% ropivacaine for bilateral rectus sheath block.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: erector spinae plane block
Description: The experimental group received ultrasound-guided erector spinae plane block, and bilateral erector spinae plane block was performed at T7 segment with 20ml 0.375% ropivacaine on each side.While the control group received ultrasound-guided transversus abdominis plane block combined with rectus sheath block, which will be performed under the costal margin with 10ml 0.375% ropivacaine for bilateral transversus abdominis plane block and 10ml 0.375% ropivacaine for bilateral rectus sheath block.